Increased Expression of Tyrosine Phosphatase SHP2 in Experimental Pneumococcal Meningitis: Correlation With Tumor Necrosis Factor-Alpha and Cerebrospinal Fluid Pleocytosis
Restricted accessOtherFirst published online March, 2008
Increased Expression of Tyrosine Phosphatase SHP2 in Experimental Pneumococcal Meningitis: Correlation With Tumor Necrosis Factor-Alpha and Cerebrospinal Fluid Pleocytosis
Protein tyrosine phosphatase SHP2 plays a crucial role in the development of the central nervous system. To explore the expression and possible role of SHP2 during the course of bacterial meningitis, this article reports a juvenile rat bacterial meningitis model established by direct intracisternal injection of Streptococcus pneumoniae. Expression of SHP2 at both mRNA and protein levels were assessed. White blood cell count and concentration of tumor necrosis factor-alpha (TNF-alpha) in cerebrospinal fluid (CSF) were also measured. In the cortex, bacterial meningitis led to a significant upregulation of mRNA encoding SHP2. SHP2 protein levels and CSF white blood cell count were positively correlated. However, there was no significant correlation between the levels of SHP2 protein and TNF-alpha concentrations in CSF. These findings do not support an essential role of SHP2 in the pathogenesis of experimental pneumoniae meningitis, but it is possible that SHP2 protein expression may be used as a marker of disease activity.
Schuchat A., Robinson K., Wenger JD, et al. Bacterial meningitis in the United States in 1995. Active surveillance team. N Engl J Med.1997;337:970-976.
2.
Cantley LC, Auger KR, Carpenter C., et al. Oncogenes and signal tranduction. Cell. 1991;64:281-302.
3.
Hunter T.Cooperation between oncogenes. Cell. 1991;64:249-270.
4.
Horvat A., Schwaiger FW, Hager G., et al. A novel role for protein tyrosine phosphatase SHP1 in controlling glial activation in the normal and injured nervous system. J Neurosci.2001;21: 865-874.
5.
Servidei T., Bhide PG, Huang Z., et al. The protein tyrosine phosphatase SHP2 is expressed in glial and neuronal progenitor cells, postmitotic neurons and reactive astrocytes . Neuroscience. 1998; 82:529-543.
Qu CK, Nguyen S., Chen J., et al. Requirement of SHP2 tyrosine phosphatase in lymphoid and hematopoietic cell development. Blood. 2001;97:911-914.
8.
WishcamperCA, Brooks DM, Douglas Coffin J., et al. Focal cerebral ischemia upregulates SHP-1 in reactive astrocytes in juvenile mice. Brain Research. 2003;974:88-98.
9.
Coimbra RS, Voisin V., de Saizieu AB, et al. Gene expression in cortex and hippocampus during acute pneumococcal meningitis. BMC Biol.2006;4:15.
10.
Herlaar E., Brown Z.MAPK signaling cascades in inflammatory disease. Mol Med Today . 1999;5:439-447.
11.
Guha M., Mackman N.LPS induction of gene expression in human monocytes. Cell Signal. 2001;13:85-94.
12.
Leib SL, Leppert D., Clements J., et al. Matrix metalloproteinases contribute to brain damage in experimental pneumococcal meningitis. Infect Immun.2000 ;68:615-620.
13.
Liu XJ, Sun RP, Lei GF, et al. The pathological mechanism and interventional measure of rat pneumococcal meningitis. ChinJ Pediatr.2005 ;43:294-296.
14.
Anthony DC, Miller KM, Fearn S., et al. Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS. J Neuroimmunol . 1998; 87:62-72.
15.
Barkai U., Prigent-Tessier A., Tessier A., et al. Suppressor of cytokine signaling in the prevention of prolactin-responsive gene expression in decidual cells. Molecular Endocrinology . 2000;14:554-563.
16.
De Groote D, Gevaert Y., Lopez M., et al. Ex vivo cytokine production by whole blood cells from cancer patients. Cancer Detect Prev.1996;20:207-213.
17.
Horwitz DA, Gray JD, Behrendsen SC, et al. Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus. Arthritis Rheum.1998;41:838-844.
18.
Leist TP, Frei K., Kam-Hansen S., et al. Tumor necrosis factor alpha in cerebrospinal fluid during bacterial, but not viral, meningitis. Evaluation in murine model infections and in patients . J Exp Med.1988;167:1743-1748.
19.
Granert C., Raud J., Waage A., et al. Effects of polysaccharide fucoidin on cerebrospinal fluid interleukin-1 and tumor necrosis factor alpha in pneumococcal meningitis in the rabbit. Infect Immun.1999;67:2071-2074.
20.
Tarlow MJ, Jenkins R., Comis SD, et al. Ependymal cells of the choroid plexus express tumour necrosis factor-alpha. Neuropathol Appl Neurobiol. 1993;19:324-328.
21.
An H., Zhao W., Hou J., et al. SHP2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production. Immunity. 2006;25:919-928.
22.
Yamamoto M. , Sato S., Hemmi H., et al. Role of adaptor TRIF in the MyD88-independent toll like receptor signaling pathway. Science. 2003;301:640-643.
23.
Tuomanen EI , Saukkonen K., Sande S., et al. Reduction of inflammation, tissue damage, and mortality in bacterial meningitis in rabbits treated with monoclonal antibodies against adhesion-promoting receptors of leukocytes. J Exp Med.1989;170:959-969.
24.
Tang LM, Chen ST, Hsu WC, et al. Acute bacterial meningitis in adults: a hospital-based epidemiological study. QJM. 1999; 92:719-725.
25.
Ostergaard C., Konradsen HB, Samuelsson S.Clinical presentation and prognostic factors of Streptococcus pneumoniae meningitis according to the focus of infection . BMC Infect Dis. 2005;5:93.
26.
Van Furth AM , Roord JJ, Van Furth R.Roles of proinflammatory and anti-inflammatory cytokines in pathophysiology of bacterial meningitis and effect of adjunctive therapy. Infect Immun. 1996; 64:4883-4890.
